Search the database for

Author(s)
Title
Abstract
Source
CMR keyword(s)
Earliest year  Latest year 
search help

The Cochrane Methodology Register (CMR) is a bibliography of publications that report on methods used in the conduct of controlled trials. It includes journal articles, books, and conference proceedings, and the content is sourced from MEDLINE and hand searches. CMR contains studies of methods used in reviews and more general methodological studies that could be relevant to anyone preparing systematic reviews. CMR records contain the title of the article, information on where it was published (bibliographic details), and, in some cases, a summary of the article. They do not contain the full text of the article.

The CMR was produced by the Cochrane UK, until 31st May 2012. There are currently no plans to reinstate the CMR and it is not receiving updates.* If you have any queries, please contact the Cochrane Community Service Team (support@cochrane.org).

The Publishers, John Wiley & Sons Ltd, thanks Update Software for the continued use of their data formats in the Cochrane Methodology Register (CMR).

*Last update in January 2019.

Title
Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data
Authors
Ioannidis JP, Contopoulos Ioannidis DG, Lau J.
Source
Journal of Clinical Epidemiology
Date of publication
1999
Volume
52
Issue
4
Pages
281-291
Abstract

Meta-analyses of randomized evidence may include published, unpublished, and updated data in an ongoing estimation process that continuously accommodates more data. Synthesis may be performed either with group data or with meta-analysis of individual patient data (MIPD). Although MIPD with updated data is considered the gold standard of evidence, there is a need for a careful study of the impact different sources of data have on a meta-analysis and of the change in the treatment effect estimates over sequential information steps. Unpublished data and late-appearing data may be different from early-appearing data. Updated information after the end of the main study follow-up may be affected by cross-overs, missing information, and unblinding. The estimated treatment effect may thus depend on the completeness and updating of the available evidence. To address these issues, we present recursive cumulative meta-analysis (RCM) as an extension of cumulative metaanalysis. Recursive cumulative meta-analysis is based on the principle of recalculating the results of a cumulative meta-analysis with each new or updated piece of information and focuses on the evolution of the treatment effect as a more complete and updated picture of the evidence becomes available. An examination of the perturbations of the cumulative treatment effect over sequential information steps may signal the presence of bias or heterogeneity in a meta-analysis. Recursive cumulative meta-analysis may suggest whether there is a true underlying treatment effect to which the meta-analysis is converging and how treatment effects are sequentially altered by new or modified evidence. The method is illustrated with an example from the conduct of an MIPD on acyclovir in human immunodeficiency virus infection. The relative strengths and limitations of both metaanalysis of group data and MIPD are discussed through the RCM perspective. OTHER PUBLCIATIONS OF THIS RESEARCH: Ioannidis J, Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. Proceedings of the National Academy of Sciences of the United States of America 2001;98(3):831-6. Ioannidis JPA, Lau J. What certainty can there be on how much treatments work: empirical insight from recursive cumulative meta-analyses [abstract] 8th Annual Cochrane Colloquium; 2000 Oct 25-29; Cape Town, South Africa:21.

CMR keywords
CMR: Data collection - individual patient data - general methods; CMR: Meta-analysis - updating and cumulative meta-analysis;CMRA5.1
Correspondence address
Therapeutics Research Program, Division of Aids, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Reference typeJournal article